Product Description: Felzartamab (MOR-202) is a human monoclonal antibody that targets CD38 and can be used in multiple myeloma research[1][2].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]J. Endell, et al. Effect of MOR202, a human CD38 antibody, in combination with lenalidomide and bortezomib, on bone lysis and tumor load in a physiologic model of myeloma.Meeting Abstract / 2011 ASCO Annual Meeting I/[2]Marc S Raab, et al. MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial. Lancet Haematol. 2020 May;7(5):e381-e394.
CAS Number: 2197112-39-1
Molecular Weight: N/A
Compound Purity: 99.34
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: CD38